GB Patent

GB9305718D0 — Medicaments

Assigned to Glaxo Group Ltd · Expires 1993-05-05 · 33y expired

What this patent protects

The present invention relates to the use of certain tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis.

USPTO Abstract

The present invention relates to the use of certain tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis.

Drugs covered by this patent

Patent Metadata

Patent number: GB9305718D0
Jurisdiction: GB
Classification: —
Expires: 1993-05-05
Drug substance claim: No
Drug product claim: No
Assignee: Glaxo Group Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.